Menu

• Ask a Health Expert about CEREBRAL MICROANGIOPATHY
• Post Your Side Effect related to CEREBRAL MICROANGIOPATHY
• CEREBRAL MICROANGIOPATHY and FDA Warnings
• CEREBRAL MICROANGIOPATHY in Patients Wiki
• Report CEREBRAL MICROANGIOPATHY in Drug Side Effect Survey

CEREBRAL MICROANGIOPATHY side effect

What is CEREBRAL MICROANGIOPATHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Gabapentin Side Effects Report #5729395-3
Consumer or non-health professional from BRAZIL reported GABAPENTIN problem on Apr 24, 2008. Female patient, 68 years of age, was diagnosed with back pain, paraesthesia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebral microangiopathy, chorea, . GABAPENTIN dosage: unknown. Patient recovered.

Avastin Side Effects Report #5748038-6
AVASTIN problem was reported by a Physician from UNITED KINGDOM on May 09, 2008. Male patient, weighting 242.5 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cerebral microangiopathy, confusional state, dementia, memory impairment, polyneuropathy, . AVASTIN dosage: 5 MG/KG, Q14D. During the same period patient was treated with IRINOTECAN, FLUOROURACIL. Patient recovered.

Prograf Side Effects Report #5517793-2
Physician from UNITED STATES reported PROGRAF problem on Nov 05, 2007. Male patient, 60 years of age, was diagnosed with renal transplant, prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cerebral artery thrombosis, cerebral microangiopathy, cerebrovascular accident, transient ischaemic attack, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, CLONIDINE, NORVASC, LABETALOL HYDROCHLORIDE, PHOSLO, MYCELEX, BICARBONATE IN PLASTIC CONTAINER. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5714813-7
REVLIMID problem was reported by a Health Professional from GERMANY on Apr 10, 2008. Male patient, 68 years of age, weighting 134.5 lb, was diagnosed with plasmacytoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral microangiopathy, convulsion, disorientation, hypokalaemia, loss of consciousness, lung neoplasm, metastases to central nervous system, . REVLIMID dosage: 25 MG, 1 X 7, ORAL. Patient was hospitalized. Patient recovered.